Clinical trial
A Study of NeoRecormon in Patients With Chronic Kidney Disease.
NCT00437723 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00437723 |
|---|---|
| Title | A Study of NeoRecormon in Patients With Chronic Kidney Disease. |
| Official title | An Open-Label Study to Investigate the Effect of NeoRecormon on Hemoglobin Level and Renal Function in Patients With Chronic Kidney Disease, Stage 2-4 |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | epoetin beta [NeoRecormon] |
| Enrollment | 90 |
| Completion | Apr 1, 2008 |
| First posted | Feb 21, 2007 |
| Last update posted | May 14, 2009 |
| Countries | Serbia |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: